Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA accepts Cell Therapeutics' resubmission of pixantrone NDA as complete

Dec. 7, 2011

Oncolytics Biotech reports on Reolysin in pancreatic cancer

Dec. 7, 2011

Belgian university discloses novel Amaryllidaceae isocarbostyryl derivatives for cancer

Dec. 7, 2011

Infinity Pharmaceuticals patents novel fatty acid synthase inhibitors

Dec. 7, 2011

U3-1287 combinations assessed in lung and pharynx cancer

Dec. 7, 2011

Human monoclonal antibodies show anticancer potential in preclinical and clinical settings

Dec. 7, 2011

Cell Therapeutics provides update on MAA for Pixuvri

Dec. 5, 2011

Researchers at GlaxoSmithKline disclose new EZH2 inhibitors

Dec. 5, 2011

Sentinel Oncology synthesizes novel Chk1 inhibitors

Dec. 5, 2011

Nerviano Medical Sciences presents preclinical findings on NMS-P948

Dec. 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...